Articles tagged with Medical Treatments
The American College of Lifestyle Medicine has published a comprehensive guideline on lifestyle interventions for treating and remitting type 2 diabetes and prediabetes. The guideline offers evidence-based strategies for optimizing lifestyle behaviors, sustaining changes, and reducing medication needs.
Researchers discover iguratimod, a rheumatoid arthritis drug, effectively treats excessive COVID-19 inflammation in mice by maintaining antiviral immune responses. The study provides hope for patients with severe COVID-19-related cytokine storms.
The small intestine's epithelial cells and immune cells work together to maintain gut integrity and regulate immune responses. Dysfunction in these cellular networks is linked to systemic diseases such as obesity, insulin resistance, and autoimmune conditions.
A cross-sectional study found significant differences in poor mental health among US workers by sociodemographic categories and industry/occupation groups. The findings suggest that work-related factors may contribute to mental health outcomes, underscoring the need for targeted prevention and treatment strategies.
Researchers developed a patient-derived organoid library to study chemotherapy resistance in esophageal cancer. Lab-grown mini-tumors showed increased activity in the NRF2 pathway, suggesting potential biomarkers for predicting chemotherapy resistance.
A new study published by Martin-Luther-Universität Halle-Wittenberg found that theophylline significantly improved symptoms and quality of life for patients with ADCY5-related dyskinesia. The treatment yielded impressive results, including reduced muscle twitches, improved gait, and better psychosocial well-being.
Stanford researchers have developed a machine learning approach to design proteins that can target specific genomic sites without triggering immune responses. By combining three independent algorithms, the team created zinc finger DNA-binding domains with improved functionality and lowered immunogenicity.
A comprehensive review reveals that early ECT sessions show substantial improvement, but subsequent sessions may lead to diminishing returns and cognitive side effects. The researchers propose a response-guided sequential treatment strategy, categorizing patients into three groups based on their response patterns.
The annual Alzheimer's disease drug development pipeline report, led by Dr. Jeffrey Cummings, highlights an increase in active clinical trials and promising drugs, offering reason for optimism. The report assesses 138 drugs currently being studied and notes the growing importance of biomarkers in clinical trials.
A new study has identified a way to target the viral enzyme uracil-DNA glycosylase (vUNG) that helps HSV-1 evade the immune system, allowing reactivation of APOBEC1 and improving survival in infected mice. This approach offers a promising therapeutic strategy for treating HSV-1 encephalitis by strengthening brain immunity.
Researchers found that histotripsy treatment reduces tumor hypoxia, triggering an anti-tumor immune response that targets distant cancer cells. This breakthrough understanding may lead to more effective treatment options with less patient side effects.
Rapid advances in cancer treatment have improved long-term survival rates, but current resources and models of care in Canada do not meet the changing needs of people with cancer. The authors propose solutions such as reducing unnecessary surveillance and establishing interdisciplinary specialty clinics.
A large clinical trial found that switching to an experimental drug after liquid biopsy detection of treatment-resistant mutations in breast cancer patients substantially extends tumor control and overall health status. The study, conducted at Weill Cornell Medicine, showed better outcomes compared to standard care.
Researchers at Weill Cornell Medicine have made new discoveries about BCG therapy, which has been shown to reprogram and amplify immune cells in the bone marrow, boosting the body's ability to fight cancer. The findings could lead to improved immunotherapies for various types of cancer.
Acupuncture was found to be an effective treatment for nocturia in survivors of prostate cancer, reducing symptoms comparable to other medications while causing fewer side effects. The study suggests acupuncture may offer a new hope for managing this common issue affecting half of prostate cancer survivors.
Researchers at Virginia Tech's Fralin Biomedical Research Institute developed a peptide therapy called JM2 that targets cancer cells' ability to renew and regrow. The treatment significantly slows tumor growth in animal models and disrupts the maintenance of treatment-resistant cancer cells.
Researchers discovered biomarkers in gut bacteria and metabolites that can help diagnose and treat gastrointestinal diseases. The study found that certain biomarkers could predict multiple diseases, including gastric cancer and inflammatory bowel disease.
Researchers identify five distinct immunotypes in tongue squamous cell carcinoma, shedding light on why current immunotherapies fail. The study's findings highlight the need for immune-based assessments to guide treatment decisions and suggest a new approach to personalized medicine.
This novel treatment approach yields better weight loss maintenance and cardiovascular risk outcomes compared to standard-of-care treatment. Patient-delivered lifestyle intervention combined with peer support significantly improves weight loss and reduces cardiovascular risk.
The University of Oldenburg has secured funding for three research clusters: Hearing4all, Ocean Floor, and NaviSense. These clusters aim to improve hearing loss prediction, diagnosis, and treatment, as well as animal navigation research. The funding enables the continuation of high-quality research with social relevance.
The European Society for Medical Oncology (ESMO) has released the latest version of the ESMO-MCBS scale, which measures the clinical benefit of cancer treatments. The new version incorporates 13 critical amendments to improve evaluation and accuracy, with a focus on patient preferences and toxicity annotations.
A new combination therapy pairing radiopharmaceutical 177Lu-DOTATATE with DNA-repair blocker olaparib has been deemed feasible and tolerable for neuroendocrine cancer patients. Eighteen patients received the combined therapy, resulting in a 69% disease control rate at six months.
A new smartphone app, ECHAS, can help people determine if they are suffering from a heart attack or stroke and need medical attention. The app, developed by experts at UVA Health and other leading institutions, proved effective in identifying patients with cardiac and neurological emergencies.
A $2.4 million grant will fund the development of an optical imaging technology to image nerve endings in cancer patients with chemotherapy-induced peripheral neuropathy. The goal is to identify potential biomarkers for the disease, enabling early detection and prevention.
Researchers successfully created over 1000 new biological tools, known as enhancer AAV vectors, that can target specific brain cell types. These tools offer unprecedented access to brain cells and hold promise for targeted gene therapies to correct genetic defects in specific cells contributing to disease.
Scientists have identified a brain molecule called NEAT1 that appears to play a central role in triggering light sensitivity (photophobia) during migraines. By disrupting the normal balance of nerve signaling and pain regulation, NEAT1 makes nerves more sensitive to light.
A retrospective study found that patients with ALS who used REM-suppressing antidepressants had a significantly higher two-year survival rate compared to those without such medications. This breakthrough suggests that inhibiting REM sleep may be a viable treatment option for ALS.
A new study published in Blood Cancer Discovery found that certain gene mutations and the maturity of leukemia cells affect how patients respond to venetoclax and hypomethylating agents. Researchers identified a subtype of acute myeloid leukemia with worse outcomes, particularly those without the NPM1 mutation.
Scientists have uncovered a previously unknown mechanism explaining how neurons survive botulinum neurotoxin type A exposure. The research found that specific tRNA fragments interact with key proteins and RNA molecules involved in regulating ferroptosis, supporting neuronal survival by blocking cell death pathways.
A new study published in Neurology Open Access found that an MRI scan can accurately diagnose multiple sclerosis (MS) in just 8 minutes, eliminating the need for a painful spinal tap. The study's findings support the use of a T2*-weighted MRI and a 'rule of six' to confirm a diagnosis without lumbar puncture.
A large cohort study found that early antibiotic treatment did not significantly improve outcomes for patients with nonsevere COVID-19. The results argue against routine antibiotic use in this population due to associated risks.
UT Dallas bioengineers have created an enhanced light-activated immunotherapy approach to target advanced stomach cancer. Lab-designed molecules are primed with far-red or near-infrared light to activate the immune system against stubborn cancer cells, reducing side effects.
A new technique using focused sound waves and microbubbles has shown great promise in treating debilitating brain lesions called cerebral cavernous malformations. The approach has halted the growth of lesions almost entirely, offering a potential paradigm shift in treatment.
Researchers found that stereotactic body radiotherapy (SBRT) is as safe as conventional treatment, with similar side effects and quality of life. SBRT shortens treatment time and may have biological advantages in targeting prostate cancer.
The new international doctoral programme, RAMP-UP, aims to improve regenerative medicine and ATMPs in Europe by training 55 doctoral students from academia, healthcare, and industry. The programme has the potential to revolutionise healthcare with advanced therapies for genetic diseases and cancers.
A recent study found that the average duration of ADHD medication for children and adolescents is more than three years. Long-term effects in children have not been sufficiently studied due to limited data on the safety of marketed ADHD medicines.
GLP1-RA treatment is associated with improvements in quality of life, restrained eating, and emotional eating behavior. The treatment also provides reassurance regarding its psychiatric safety profile.
Researchers have identified conditions under which ultra-high dose rate carbon ion beams can spare normal cells while maintaining tumor control, opening new possibilities for safer radiotherapy. The study reveals a cell-sparing effect under normoxic conditions using higher linear energy transfer values.
A breakthrough all-oral treatment for a rare but deadly strain of sleeping sickness is now available, revolutionizing care for patients in endemic countries. Fexinidazole Winthrop has been approved for use in several African countries and is being distributed by WHO, offering a safer alternative to existing treatments.
A 72-week clinical trial found tirzepatide to be more effective than semaglutide in reducing body weight and waist circumference. The study demonstrated that tirzepatide's dual mechanism of action, mimicking both GLP-1 and GIP hormones, is key to its superior performance.
Researchers found that phospholipids in ascites fluid disrupt immune cell function, particularly NK cells, leading to impaired anti-tumor activity. Blocking these lipids can restore NK cell activity, providing a promising therapeutic target.
Researchers investigated the efficacy of a combination of atorvastatin and dexamethasone in treating patients with subacute subdural hematoma (sASDH). The study found significant symptom improvement and no recurrence or progression of symptoms in all five patients treated with this regimen. Non-surgical interventions for sASDH are ofte...
Researchers discovered 500 cryptic peptides found only in pancreatic tumors, which could be targeted by vaccines or engineered T cells to attack the cancer. The peptides were identified using immunopeptidomics and shown to slow down tumor growth in mice.
Researchers found that patients taking HIV drugs called NRTIs are substantially less likely to develop Alzheimer's disease. The study, led by Jayakrishna Ambati, analyzed data from two large health insurance databases and determined a significant reduction in Alzheimer's risk among patients on NRTIs.
Researchers from Mass General Brigham presented key findings from multiple innovative studies on gene and cell therapy, focusing on rare diseases, brain cancer, and neurodegenerative disorders. The studies explored strategies to improve care delivery and accelerate translation from lab to clinic, with potential breakthroughs in treatin...
Researchers investigated the clinical outcomes of concurrent TTFields therapy with CRT in patients with newly diagnosed glioblastoma, finding no significant difference in survival outcomes compared to adjuvant therapy. The study also showed comparable safety profiles for both treatment groups.
This study found a decline in racial and ethnic disparities in receipt of ERBB2-targeted therapies among older Medicare beneficiaries with ERBB2-positive breast cancer. The narrowing of disparities may be attributed to changes in healthcare practices or policies over time.
A cross-sectional study finds a doubling in nicotine pouch past-30-day use and an increase in pouch plus e-cigarette dual use, leading to decreased exclusive e-cigarette use among US 10th and 12th graders. Prioritizing surveillance, regulation, and prevention strategies is crucial for addressing pediatric nicotine pouch use.
Researchers at TUM developed an AI-powered algorithm to predict kidney damage in prostate cancer patients undergoing lutetium-177 PSMA therapy. Early detection could enable personalized treatment adjustments to prevent organ damage.
A new AI model developed by Uppsala University accurately diagnoses multiple sclerosis (MS) with an overall accuracy of 90%, identifying the transition from relapsing-remitting to secondary progressive MS in almost 87% of cases. This enables earlier diagnosis, reducing the risk of patients receiving ineffective medicines.
Researchers identified risk factors for sudden unusual mental or somatic experiences, including past psychedelic use, reality distorting practices, and extensive spiritual practice. These findings can help clinicians diagnose and treat associated suffering, and inform the development of practical guidelines.
Researchers developed an automated machine learning program to identify potential cardiovascular incidents and fall/fracture risks based on bone density scans. The algorithm shortened screening time and found moderate to high AAC levels in 58% of older individuals, placing them at high risk of heart attack and stroke.
A cohort study of pregnant individuals with opioid use disorder found that buprenorphine treatment was associated with improved maternal and infant outcomes. The study highlights the need to improve access to treatment nationwide for these patients.
A multicenter study found that radiologically unstable plaque, particularly intraplaque hemorrhage, significantly increases the risk of ischemic stroke and ocular symptoms in patients with symptomatic mild carotid stenosis. Surgical intervention, such as carotid endarterectomy, may be a protective factor for these patients.
Patients who develop epilepsy after a traumatic brain injury are at an increased risk of premature death, with a mortality rate 1.8 times higher than those without epilepsy. The study also found that the risk of developing epilepsy is highest in the first year after the injury.
A randomized clinical trial suggests that metformin can be an effective treatment for symptomatic knee osteoarthritis in people with overweight or obesity. The study's results support the use of metformin for this condition, but further confirmation is needed in larger clinical trials.
Research reveals subpar healthcare services in Global South cities, with frequent medicine shortages and inadequate long-term condition management. Innovative policy approaches are needed to balance public service expansion and private subsidies to improve access and equity for marginalized populations.
A study of nearly 11,000 individuals found that men with panic disorder are more vulnerable to developing problematic drinking behaviors than women, potentially due to self-medication. The research highlights the need for sex-specific assessment and intervention strategies in treating comorbid conditions
A survey study found that more than 1 in 7 adults carried medical debt in 2023, with 1 in 3 forgoing mental health care the following year. Medical debt may exacerbate treatment gaps by raising thresholds for seeking care and eroding patient trust.
Researchers developed fluorescent polyionic nanoclays that can be customized for medical imaging, sensor technology, and environmental protection. These tiny clay-based materials exhibit high brightness and versatility, enabling precise tuning of optical properties.